Atherosclerosis is a chronic cardiovascular disease associated with oxidative stress damage, which is caused by excessive oxidation of low-density lipoprotein (ox-LDL). The role of microRNA miR-34a-5p on oxidative stress in ox-LDL–treated macrophages was investigated in this study.
Methods
Flow cytometry was prepared for assessing THP1-derived macrophage apoptosis. The protein and expression levels of miR-34a-5p and MDM4 were examined by Western blot and RT-qPCR, respectively. We also measured the levels of total cholesterol (TC) and triglyceride to determine the lipid accumulation. Subsequently, the activities of superoxide dismutase, malondialdehyde, and reactive oxygen species revealed the level of oxidative stress injury after miR-34a-5p and MDM4 knockdown.
Results
After ox-LDL treatment, cell apoptosis of macrophages increased in a dose-dependent and time-dependent manner. With the increase of ox-LDL treatment and the prolongation of treatment time, the expression level of miR-34a-5p was upregulated. Next, interfering with miR-34a-5p inhibited lipid accumulation and oxidative stress injury in ox-LDL–stimulated macrophages. MDM4 was a target gene of miR-34a-5p and was upregulated in ox-LDL–stimulated macrophages. With the increase of ox-LDL treatment and the prolongation of treatment time, the expression level of MDM4 was downregulated. Importantly, MDM4 knockdown partially counteracted the inhibitory effect of miR-34a-5p on oxidative stress injury.
Conclusion
MicroRNA miR-34a-5p knockdown suppressed oxidative stress injury via MDM4 in ox-LDL–treated macrophages.
MartinetWCoornaertIPuylaertP, et al.Macrophage death as a pharmacological target in atherosclerosis. Front Pharmacology2019; 10: 306. 2019/04/26. DOI: 10.3389/fphar.2019.00306.
YuanJUsmanADasT, et al.Imaging carotid atherosclerosis plaque ulceration: comparison of advanced imaging modalities and recent developments. Am J Neuroradiology2017; 38: 664–671. 2016/12/23. DOI: 10.3174/ajnr.A5026.
4.
SuciuCFPreteMRuscittiP, et al.Oxidized low density lipoproteins: the bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. Autoimmun Reviews2018; 17: 366–375. 2018/02/10. DOI: 10.1016/j.autrev.2017.11.028.
5.
SahebkarA. Dual effect of curcumin in preventing atherosclerosis: the potential role of pro-oxidant-antioxidant mechanisms. Nat Product Research2015; 29: 491–492. 2014/09/06. DOI: 10.1080/14786419.2014.956212.
ShanDKZhouYWangYX, et al.Population-based cohort study in outcome of phased progression of atherosclerosis in China (PERSUADE): objective, rationale and design. J Geriatric Cardiology : JGC2017; 14: 491–495. 2017/11/02. DOI: 10.11909/j.issn.1671-5411.2017.08.001.
8.
SlyperAH. Low-density lipoprotein density and atherosclerosis. Jama1994; 272: 305–308. 1994/07/27.
9.
SawamuraTKumeNAoyamaT, et al.An endothelial receptor for oxidized low-density lipoprotein. Nature1997; 386: 73–77. 1997/03/06. DOI: 10.1038/386073a0.
10.
CominaciniLRigoniAPasiniAF, et al.The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem2001; 276: 13750–13755. 2001/03/30. DOI: 10.1074/jbc.M010612200.
MooreKJSheedyFJFisherEA. Macrophages in atherosclerosis: a dynamic balance. Nat Reviews Immunol2013; 13: 709–721. 2013/09/03. DOI: 10.1038/nri3520.
13.
TabasI. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Reviews Immunol2010; 10: 36–46. 2009/12/05. DOI: 10.1038/nri2675.
14.
NagyLTontonozPAlvarezJGA, et al.Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell1998; 93: 229–240. 1998/05/06. DOI: 10.1016/s0092-8674(00)81574-3.
15.
RyterSWKimHPHoetzelA, et al.Mechanisms of cell death in oxidative stress. Antioxid Redox Signaling2007; 9: 49–89. 2006/11/23. DOI: 10.1089/ars.2007.9.49.
16.
ParathathSMickSLFeigJE, et al.Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism. Circ Research2011; 109: 1141–1152. 2011/09/17. DOI: 10.1161/circresaha.111.246363.
HammondSM. An overview of microRNAs. Adv Drug Delivery Reviews2015; 87: 3–14. 2015/05/17. DOI: 10.1016/j.addr.2015.05.001.
19.
GhildiyalMZamorePD. Small silencing RNAs: an expanding universe. Nat Reviews Genet2009; 10: 94–108. 2009/01/17. DOI: 10.1038/nrg2504.
20.
MendellJTOlsonEN. MicroRNAs in stress signaling and human disease. Cell2012; 148: 1172–1187. 2012/03/20. DOI: 10.1016/j.cell.2012.02.005..
21.
HosinAAPrasadAViiriLE, et al.MicroRNAs in atherosclerosis. J Vascular Research2014; 51: 338–349. 2014/12/17. DOI: 10.1159/000368193.
22.
HuXMaRFuW, et al.LncRNA UCA1 sponges miR‐206 to exacerbate oxidative stress and apoptosis induced by ox‐LDL in human macrophages. J Cellular Physiology2019; 234: 14154–14160. 2019/01/12. DOI: 10.1002/jcp.28109.
23.
ChenDDHuiLLZhangXC, et al.NEAT1 contributes to ox‐LDL‐induced inflammation and oxidative stress in macrophages through inhibiting miR‐128. J Cellular Biochemistry2018; 120: 2493–2501. 2018/09/12. DOI: 10.1002/jcb.27541.
24.
LiuHMaoZZhuJ, et al.MiR-140-5p inhibits oxidized low-density lipoprotein-induced oxidative stress and cell apoptosis via targeting toll-like receptor 4. Gene Ther2021; 28: 413–421. 2020/03/24. DOI: 10.1038/s41434-020-0139-7.
25.
ShanZYaoCLiZL, et al.Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice. Chin Medical Journal2013; 126: 515–520. 2013/02/21.
26.
GecysDTatarunasVVeikutieneA, et al.New potential modulators of CYP4F2 enzyme activity in angina pectoris: hsa-miR-24-3p and hsa-miR-34a-5p. Biomarkers: Bio indic of Expos, Resp2020; 25: 40–47. 2019/11/07. DOI: 10.1080/1354750x.2019.1690580.
HuangY-QCaiA-PChenJ-Y, et al.The relationship of plasma miR-29a and oxidized low density lipoprotein with atherosclerosis. Cell Physiol Biochem2016; 40: 1521–1528. 2016/12/21. DOI: 10.1159/000453202.
29.
BobryshevYVIvanovaEAChistiakovDA, et al.Macrophages and their role in atherosclerosis: Pathophysiology and transcriptome analysis. Bio Resea Int2016; 2016: 9582430. 2016/08/06. DOI: 10.1155/2016/9582430.
30.
HaoXZFanHM. Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway. Eur Review Medical Pharmacolo Sciences2017; 21: 2725–2733. 2017/07/06.
31.
ChenZWangMHeQ, et al.MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1. Exp Therapeutic Medicine2017; 13: 1702–1710. 2017/06/02. DOI: 10.3892/etm.2017.4171.
32.
LiYYangCZhangL, et al.MicroRNA-210 induces endothelial cell apoptosis by directly targeting PDK1 in the setting of atherosclerosis. Cell Molecular Biology letters2017; 22: 3. 2017/05/26. DOI: 10.1186/s11658-017-0033-5.
33.
BianchiERubertiSRontauroliS, et al.Role of miR-34a-5p in hematopoietic progenitor cells proliferation and fate decision: Novel insights into the pathogenesis of primary myelofibrosis. Int Journal Molecular Sciences2017; 18: 145. 201701/19. DOI: 10.3390/ijms18010145.
34.
WakasugiTShimizuIYoshidaY, et al.Role of smooth muscle cell p53 in pulmonary arterial hypertension. PloS One2019; 14: e0212889. 2019/02/27. DOI: 10.1371/journal.pone.0212889.
35.
ThompsonTAndreeffMStudzinskiGP, et al.1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53. Mol Cancer Therapeutics2010; 9: 1158–1168. 2010/04/22. DOI: 10.1158/1535-7163.Mct-09-1036.
36.
LiYXiaoLLiJ, et al.MicroRNA profiling of diabetic atherosclerosis in a rat model. Eur Journal Medical Research2018; 23: 55. 2018/11/06. DOI: 10.1186/s40001-018-0354-5.
37.
LiuYZhangWLGuJJ, et al.Exosome-mediated miR-106a-3p derived from ox-LDL exposed macrophages accelerated cell proliferation and repressed cell apoptosis of human vascular smooth muscle cells. Eur Review Medical Pharmacolo Sciences2020; 24: 7039–7050. 2020/07/08. DOI: 10.26355/eurrev_202006_21697.
38.
CaiTCuiXZhangK, et al.LncRNA TNK2‐AS1 regulated ox‐LDL‐stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR‐150‐5p. J Cellular Molecular Medicine2019; 23: 7289–7298. 2019/08/31. DOI: 10.1111/jcmm.14575.
39.
HuM-YDuX-BHuH-B, et al.MiR-410 inhibition induces HUVECs proliferation and represses ox-LDL-triggered apoptosis through activating STAT3. Biomed Pharmacother2018; 101: 585–590. 2018/03/09. DOI: 10.1016/j.biopha.2018.02.111.
40.
HangLPengYXiangR, et al.Ox-LDL causes endothelial cell injury through ASK1/NLRP3-Mediated inflammasome activation via endoplasmic reticulum stress. Drug Design, Development Therapy2020; 14: 731–744. 2020/03/12. DOI: 10.2147/dddt.S231916.
